(Q35917465)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482218%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

review article

1 reference

title

Prevention of HIV-associated opportunistic infections and diseases in the age of highly active antiretroviral therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482218%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

main subject

anti-retroviral agent

0 references

prevention of HIV/AIDS

0 references

opportunistic infection

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482218%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Patrick Willemot

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482218%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482218%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anti-infective Therapy

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482218%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482218%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482218%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

521-532

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482218%20AND%20SRC:MED&resulttype=core&format=json

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Natural history of HIV infection in the era of combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Cats and toxoplasmosis risk in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Tr

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Atovaquone for salvage treatment and suppression of toxoplasmic encephalitis in patients with AIDS. Atovaquone/Toxoplasmic Encephalitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

AIDS across Europe, 1994-98: the EuroSIDA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

HIV and pulmonary tuberculosis: the impact goes beyond those infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American He

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Papanicolaou smears in human immunodeficiency virus-seropositive women during follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Cancer in a population-based cohort of men and women in registered homosexual partnerships

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

The interaction of human immunodeficiency virus infection and hepatitis B virus infection in infected homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Structured treatment interruptions for the management of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Progressive multifocal leucoencephalopathy with unusual inflammatory response during antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Stopping primary prophylaxis in HIV-1-infected patients at high risk of toxoplasma encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Possible Effectiveness of Clarithromycin and Rifabutin for Cryptosporidiosis Chemoprophylaxis in HIV Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

Risk for Developing Tuberculosis among Anergic Patients Infected with HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.521

21 January 2018

Identifiers

DOI

10.1586/14787210.2.4.521

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482218%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference